Harbin Medisan Pharmaceutical Co.,Ltd. Posted 38.3 Million Yuan Net Profit in First Quarter of 2023

Harbin Medisan Pharmaceutical Co.,Ltd. (哈尔滨三联药业股份有限公司) (002900.SZ) reported a net profit of 38.3 million yuan in the first quarter of 2023, reversing a net loss of 1.8 million yuan for the same period in the previous year.

Meanwhile, the company posted 342.1 million yuan in revenue, up 33.3% year-on-year.

At the end of the reporting period, it had 3.4 billion yuan in total assets and 1.3 billion yuan in total liabilities, with a liability-to-asset ratio of 38.3%.